Literature DB >> 9724876

Polymerase chain reaction approaches for the detection of Neospora caninum and Toxoplasma gondii.

J T Ellis1.   

Abstract

This review summarizes existing knowledge on the development and use of the polymerase chain reaction for the detection of DNA from Neospora and Toxoplasma. Several strategies which utilise the polymerase chain reaction for the diagnosis of toxoplasmosis in humans and livestock have been described and they principally target the B1 repetitive sequence, the P30 gene or ribosomal DNA. Experience has shown that the polymerase chain reaction has proven insufficiently robust to serve as a diagnostic test alone although when used in conjunction with other diagnostic techniques it does prove to be a useful aid. The marketing of a commercial polymerase chain reaction kit may well solve some of the inadequacies seen using "home made" polymerase chain reaction technology which are commonly used in diagnostic laboratories around the world. Recent progress on the development of polymerase chain reaction diagnostics for Neospora has been rapid and is discussed in detail.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724876     DOI: 10.1016/s0020-7519(98)00096-4

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  15 in total

1.  Evaluation of a PCR based on primers to Nc5 gene for the detection of Neospora caninum in brain tissues of bovine aborted fetuses.

Authors:  V S O Paula; A A R Rodrigues; L J Richtzenhain; A Cortez; R M Soares; S M Gennari
Journal:  Vet Res Commun       Date:  2004-10       Impact factor: 2.459

2.  Unexpected Diagnosis of Cerebral Toxoplasmosis by 16S and D2 Large-Subunit Ribosomal DNA PCR and Sequencing.

Authors:  Alexandra Y C Kruse; Lasse Kvich; Steffen Eickhardt; Lars H Omland; Thomas Bjarnsholt; Claus Moser
Journal:  J Clin Microbiol       Date:  2015-04-08       Impact factor: 5.948

3.  Detection by PCR of Neospora caninum in fetal tissues from spontaneous bovine abortions.

Authors:  T V Baszler; L J Gay; M T Long; B A Mathison
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  Misdiagnosis of toxoplasma infection by PCR: fears unfounded.

Authors:  M Bhalla; J D Johnson; R E Holliman; D Savva
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

5.  Real-time PCR for quantitative detection of Toxoplasma gondii.

Authors:  M H Lin; T C Chen; T T Kuo; C C Tseng; C P Tseng
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

6.  Quantitative detection of Neospora caninum in bovine aborted fetuses and experimentally infected mice by real-time PCR.

Authors:  Esther Collantes-Fernández; Angel Zaballos; Gema Alvarez-García; Luis M Ortega-Mora
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Application of real-time fluorescent PCR for quantitative assessment of Neospora caninum infections in organotypic slice cultures of rat central nervous system tissue.

Authors:  Norbert Müller; Nathalie Vonlaufen; Christian Gianinazzi; Stephen L Leib; Andrew Hemphill
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

8.  Aspects of toxoplasma infection on the reproductive system of experimentally infected rams (ovis aries).

Authors:  Welber Daniel Zanetti Lopes; Alvimar José da Costa; Luis Fernando Santana; Ricardo Silva Dos Santos; Walter Matheus Rossanese; Wilton Carlos Zanetti Lopes; Gustavo Henrique Nogueira Costa; Cláudio Alessandro Sakamoto; Thais Rabelo Dos Santos
Journal:  J Parasitol Res       Date:  2009-05-27

9.  Neospora caninum and complex vertebral malformation as possible causes of bovine fetal mummification.

Authors:  Mohamed Elshabrawy Ghanem; Toshihiko Suzuki; Masashi Akita; Masahide Nishibori
Journal:  Can Vet J       Date:  2009-04       Impact factor: 1.008

10.  Development of a PCR-enzyme immunoassay oligoprobe detection method for Toxoplasma gondii oocysts, incorporating PCR controls.

Authors:  Kellogg J Schwab; James J McDevitt
Journal:  Appl Environ Microbiol       Date:  2003-10       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.